MrACT (GenBank accession No
Advanced treatment technologies such as ozonation, activated carbon filtration, and membrane bioreactors have shown promise in removing pharmaceutical contaminants more effectively than conventional treatment processes
4.7 The products of microbiome (SCFAs) indirectly protect the esophagus from multiple pathways and have potential for the treatment of GERD Microorganisms in the colon are capable of fermenting indigestible food components and consuming prebiotics to produce short-chain fatty acids (SCFAs) (78, 79) The relationship between SCFAs and GERD is not yet clear, but known studies have found that SCFAs have some potential for treating GERD ( Figure 2 )
The GLP-1 Boom: A Drug Class Redefining the Obesity Market Welcome to Market Watch: Pharma, Biotech and Healthcare GLP-1 drugs have triggered one of the fastest commercial expansions in pharmaceutical history
33,34 After oral administration, absorption of glutathione is very poor mainly due to hydrolysis by intestinal and hepatic -glutamyltransferase as mentioned above, and for that reason, most therapeutic approaches using the oral route struggle to achieve results and the patients seek less safe treatments like intravenous treatment often under uncontrolled situations which may not be medically supervised, in some countries
UCT-MSC-EXs, umbilical cord tissue mesenchymal stem cell and exosomes
